參考文獻

[1] 石漢平.腫瘤營養療法[J].中國腫瘤臨床，2014，41（18）：1141-1145.

[2]ARENDS J，BARACOS V，BERTZ H，et al.ESPEN expert group recommendations for action against cancerrelated malnutrition[J].Clin Nutr，2017，36（5）：1187-1196.

[3]CEDERHOLM T，BOSAEUS I，BARAZZONI R，et al.Diagnostic criteria for malnutrition-An ESPEN Consensus Statement[J].Clin Nutr，2015，34（3）：335-340.

[4]CEDERHOLM T，BARAZZONI R，AUSTIN P，et al.ESPEN guidelines on definitions and terminology of clinical nutrition[J].Clin Nutr，2017，36（1）：49-64.

[5]SOBOTKA L.Basics in clinical nutrition[M].4th ed.Iran.Galen，2012.

[6]SONG C，CAO J，ZHANG F，et al.Nutritional risk assessment by Scored Patient-Generated Subjective Global Assessment associated with demographic characteristics in 23，904 common malignant tumors patients[J].Nutr Cancer，2019，1-11.

[7]石漢平，凌文華，李薇.腫瘤營養學[M].北京：人民衛生出版社，2012.

[8]CEDERHOLM T，JENSEN G L，CORREIA M I T D，et al.GLIM criteria for the diagnosis of malnutrition-A consensus report from the global clinical nutrition community[J].Clin Nutr，2019，38（1）：1-9.

[9]JENSEN G L，CEDERHOLM T，CORREIA M I T D，et al.GLIM criteria for the diagnosis of malnutrition：a consensus report from the global clinical nutrition community[J].JPEN J Parenter Enteral Nutr，2019，43（1）：32-40.

[10]FEARON K，STRASSER F，ANKER S D，et al.Definition and classification of cancer cachexia：an international consensus[J].Lancet Oncol，2011，12（5）：489-495.

[11]BARACOS V E，MAZURAK V C，BHULLAR A S.Cancer cachexia is defined by an ongoing loss of skeletal muscle mass[J].Ann Palliat Med，2019，8（1）：3-12.

[12]YANG Q J，ZHAO J R，HAO J，et al.Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia[J].J Cachexia Sarcopenia Muscle，2018，9（1）：71-85.

[13]CRAWFORD J.What are the criteria for response to cachexia treatment?[J].Ann Palliat Med，2019，8（1）：43-49.

[14]MARTIN L，SENESSE P，GIOULBASANIS I，et al.Diagnostic criteria for the classification of cancer-associated weight loss[J].J Clin Oncol，2015，33（1）：90-99.

[15]CRUZ-JENTOFT A J，BAEYENS J P，BAUER J M，et al.European working group on Sarcopenia in older people.Sarcopenia：European consensus on definition and diagnosis：report of the European working group on sarcopenia in older people[J].Age Ageing，2010，39（4）：412-423.

[16]CRUZ-JENTOFT A J，BAHAT G，BAUER J，et al.Sarcopenia：revised European consensus on definition and diagnosis[J].Age Ageing，2019，48（1）：16-31.

[17]SAYER A A，SYDDALL H，MARTIN H，et al.The developmental origins of sarcopenia[J].J Nutr Health Aging，2008，12（7）：427-432.

[18]SAYER A A，SYDDALL H E，MARTIN H J，et al.Falls，sarcopenia，and growth in early life：findings from the Hertfordshire cohort study[J].Am J Epidemiol，2006，164（7）：665-671.

[19] 陳梅梅，石漢平.肌肉功能評價方法[J].腫瘤代謝與營養電子雜志，2014，1（3）：49-52.

[20]石漢平，李薇，齊玉梅，等.營養篩查與評估[M].北京：人民衛生出版社，2014.

[21]FEARON K，STRASSER F，ANKER S D，et al.Definition and classification of cancer cachexia：an international consensus[J].Lancet Oncol，2011，12（5）：489-495.

[22]MARTIN L，SENESSE P，GIOULBASANIS I，et al.Diagnostic criteria for the classification of cancer-associated weight loss[J].J Clin Oncol，2015，33（1）：90-99.

[23] 石漢平，趙青川，王昆華，等.營養不良的三級診斷[J].腫瘤代謝與營養電子雜志，2015，2（2）：31-36.

[24]JONES JM.The methodology of nutritional screening and assessment tools[J].J Hum Nutr Diet，2002，15（1）：59-71.

[25]OTTERY FD.Rethinking nutritional support of the cancer patient：the new field of nutritional oncology[J].Semin Oncol，1994，21（6）：770-778.

[26]FU Z M，XU H X，SONG C H，et al.Validity of the Chinese version of the Patient-Generated Subjective Global Assessment（PG-SGA） in lung cancer patients[J].J Nutr Oncol，2016，1（1）：52-58.

[27]石漢平，江華，李薇，等.中國腫瘤營養治療指南[M].北京：人民衛生出版社，2015.

[28]MCMILLAN D C.The systemic inflammation-based Glasgow Prognostic Score：a decade of experience in patients with cancer[J].Cancer Treat Rev，2013，39（5）：534-540.

[29]DOLAN R D，LAIRD B J A，HORGAN P G，et al.The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer： A systematic review[J].Crit Rev Oncol Hematol， 2018，132：130-137.

[30]WEIJS P J，STAPEL S N，DE GROOT S D，et al.Optimal protein and energy nutrition decreases mortality in mechanically ventilated，critically ill patients：a prospective observational cohort study[J].JPEN J Parenter Enteral Nutr，2012，36（1）：60-68.

[31]ALBERDA C，GRAMLICH L，JONES N，et al.The relationship between nutritional intake and clinical outcomes in critically ill patients：results of an international multicenter observational study[J].Intensive Care Med，2009，35（10）：1728-1737.

[32]VILLET S，CHIOLERO R L，BOLLMANN M D，et al.Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients[J].Clin Nutr，2005，24（4）：502-509.

[33]FERRIOLLI E，SKIPWORTH R J，HENDRY P，et al.Physical activity monitoring：a responsive and meaningful patient-centered outcome for surgery，chemotherapy，or radiotherapy?[J].J Pain Symptom Manage，2012，43（6）：1025-1035.

[34]PURCELL S A，ELLIOTT S A，BARACOS V E，et al.Key determinants of energy expenditure in cancer and implications for clinical practice[J].Eur J Clin Nutr，2016，70（11）：1230-1238.

[35]BOZZETTI F，ARENDS J，LUNDHOLM K，et al.ESPEN Guidelines on Parenteral Nutrition：non-surgical oncology[J].Clin Nutr，2009，28（4）：445-454.

[36]BAUER J，BIOLO G，CEDERHOLM T，et al.Evidence-based recommendations for optimal dietary protein intake in older people：a position paper from the PROT-AGE Study Group[J].J Am Med Dir Assoc，2013，14（8）：542-559.

[37]BOZZETTI F，BOZZETTI V.Is the intravenous supplementation of amino acid to cancer patients adequate?A critical appraisal of literature[J].Clin Nutr，2013，32（1）：142-146.

[38]COMPHER C，CHITTAMS J，SAMMARCO T，et al.Greater protein and energy intake may be associated with improved mortality in higher risk critically ill patients：a multicenter，multinational observational study[J].Crit Care Med，2017，45（2）：156-163.

[39]石漢平，許紅霞，李蘇宜，等.營養不良的五階梯治療[J].腫瘤代謝與營養電子雜志，2015，2（1）：29-33.

[40]JIANG W，DING H，LI W，et al.Benefits of oral nutritional supplements in patients with locally advanced nasopharyngeal cancer during concurrent chemoradiotherapy：an exploratory prospective randomized trial[J].Nutr Cancer，2019：1-9.

[41]呂家華，李濤，朱廣迎，等.食管癌同步放化療聯合腸內營養治療前瞻性多中心隨機對照臨床研究中期結果報告[J].腫瘤代謝與營養電子雜志，2016，3（4）：239-242.

[42]TANAKA N，TAKEDA K，KAWASAKI Y，et al.Early intensive nutrition intervention with dietary counseling and oral nutrition supplement prevents weight loss in patients with advanced lung cancer receiving chemotherapy：a clinical prospective study.Yonago Acta Med，2018，61（4）：204-212.

[43]HATAO F，CHEN KY，WU JM，et al.Randomized controlled clinical trial assessing the effects of oral nutritional supplements in postoperative gastric cancer patients[J].Langenbecks Arch Surg.2017，402（2）：203-211.

[44]CEREDA E，CAPPELLO S，COLOMBO S，et al.Nutritional counseling with or without systematic use of oral nutritional supplements in head and neck cancer patients undergoing radiotherapy[J].Radiother Oncol，2018，126（1）：81-88.

[45]CACCIALANZA R，CEREDA E，CARACCIA M，et al.Early 7-day supplemental parenteral nutrition improves body composition and muscle strength in hypophagic cancer patients at nutritional risk[J].Support Care Cancer，2019，27（7）：2497-2506.

[46]BOZZETTI F.Nutritional interventions in elderly gastrointestinal cancer patients：the evidence from randomized controlled trials[J].Support Care Cancer，2019，27（3）：721-727.

[47]SHANG E，WEISS C，POST S，et al.The influence of early supplementation of parenteral nutrition on quality of life and body composition in patients with advanced cancer[J].JPEN J Parenter Enteral Nutr，2006，30（3）：222-230.

[48]FABIAN C J，KIMLER B F，HURSTING S D.Omega-3 fatty acids for breast cancer prevention and survivorship[J].Breast Cancer Res，2015，17：62.

[49]AUCOIN M，COOLEY K，KNEE C，et al.Fish-derived Omega-3 fatty acids and prostate cancer：a systematic review[J].Integr Cancer Ther，2017，16（1）：32-62.

[50]SONG M，OU F S，ZEMLA T J，et al.Marine omega-3 fatty acid intake and survival of stage Ⅲ colon cancer according to tumor molecular markers in NCCTG Phase Ⅲ trial N0147 （Alliance）[J].Int J Cancer，2019，145（2）：380-389.

[51]NIE C，HE T，ZHANG W，et al.Branched chain amino acids：beyond nutrition metabolism[J].Int J Mol Sci，2018，19（4）pii：E954.

[52]BUMRUNGPERT A，PAVADHGUL P，NUNTHANAWANICH P，et al.Whey protein supplementation improves nutritional status，glutathione levels，and immune function in cancer patients：a randomized，doubleblind controlled trial[J].J Med Food，2018，21（6）：612-616.

[53]ENGELEN M P，SAFAR A M，BARTTER T，et al.High anabolic potential of essential amino acid mixtures in advanced nonsmall cell lung cancer[J].Ann Oncol，2015，26（9）：1960-1966.

[54]CRUZ-JENTOFT A J.Beta-Hydroxy-Beta-Methyl Butyrate （HMB）：from experimental data to clinical evidence in sarcopenia[J].Curr Protein Pept Sci，2018，19（7）：668-672.

[55]RITTIG N，BACH E，THOMSEN H H，et al.Anabolic effects of leucine-rich whey protein，carbohydrate，and soy protein with and without β-hydroxy-β-methylbutyrate （HMB） during fasting-induced catabolism：a human randomized crossover trial[J].Clin Nutr，2017，36（3）：697-705.

[56]BEAL F L R，BEAL P R，BEAL J R，et al.Perspectives on the therapeutic benefits of arginine supplementation in cancer treatment[J].Endocr Metab Immune Disord Drug Targets，2019，19（7）：913-920.

[57]MARIMUTHU K，VARADHAN K K，LJUNGQVIST O，et al.A meta-analysis of the effect of combinations of immune modulating nutrients on outcome in patients undergoing major open gastrointestinal surgery[J].Ann Surg，2012，255（6）：1060-1068.

[58]WEIMANN A，BRAGA M，CARLI F，et al.ESPEN guideline：Clinical nutrition in surgery[J].Clin Nutr，2017，36（3）：623-650.

[59]BRAGA M，LJUNGQVIST O，SOETERS P，et al.ESPEN Guidelines on Parenteral Nutrition：surgery[J].Clin Nutr，2009，28（4）：378-386.

[60]蔣朱明.臨床診療指南：腸外腸內營養學分冊（2008版）[M].北京：人民衛生出版社，2008.

[61]袁凱濤，石漢平.?歐洲臨床營養和代謝學會指南：外科臨床營養?解讀[J].中國實用外科雜志，2017，37（10）：1132-1134.

[62]MOYA P，MIRANDA E，SORIANO-IRIGARAY L，et al.Perioperative immunonutrition in normo-nourished patients undergoing laparoscopic colorectal resection[J].Surg Endosc，2016，30（11）：4946-4953.

[63] 石漢平.營養治療的療效評價[J].腫瘤代謝與營養電子雜志，2017，4（4）：364-370.

[64]MARIETTE C，DE BOTTON M L，PIESSEN G.Surgery in esophageal and gastric cancer patients：what is the role for nutrition support in your daily practice?[J].Ann Surg Oncol，2012，19（7）：2128-2134.

[65] 石漢平，楊劍，張艷.腫瘤患者營養教育[J/CD].腫瘤代謝與營養電子雜志，2017，4（1）：1-6.

[66]叢明華，石漢平.腫瘤患者簡明膳食自評工具的發明[J].腫瘤代謝與營養電子雜志，2018，5（1）：11-13.

[67]石漢平.腫瘤營養：石漢平2018觀點[M].北京：科學技術文獻出版社，2018.

[68]石漢平.惡性腫瘤病人營養診斷及實施流程[J].中國實用外科雜志，2018，38（3）：257-261.